Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
Related Posts
Yan MJ, Chou PP, Roberts AM, Jeong CY, Johnsen N, Katz A, Ma EJ, Nong Y, Armstrong AW. The Colors Beneath: More Than a Skin[...]
Holtsche MM, van Beek N, Hammers CM, Vorobyev A, Kasperkiewicz M, Schumacher N, Muck P, Schmidt E. Adjuvant therapy of severe and/or refractory bullous pemphigoid[...]
Wu M, Yang S, Yang Z, Fan J, Lomeli SH, Dharanipragada P, Moriceau G, Damoiseaux R, Kelley MC, Prieto-Granada CN, Giubellino A, Nosrati M, Kashani-Sabet[...]